Oral Proteins and Peptides Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Drug Type (Octreotide, Linaclotide, Insulin, Plecanatide, Calcitonin); Application (Hormonal Disorders, Gastric and Digestive Disorders, Diabetes, Bone Diseases)
Report Code: TIPRE00007436 No. of Pages: 150 Category: Pharmaceuticals Status: Upcoming
MARKET INTRODUCTION
Oral protein and Peptides are an important class of medicines that are administered through the oral route to treat the diseases, which include hormonal, gastric, and metabolic disorders. The oral protein and peptides have a significant potential to improve human health and are finding applications in the treatment of several diseases. Oral protein and peptides are used in many chronic disease, diabetes is one of them.
MARKET DYNAMICS
The oral proteins and peptides market is increasing its collaboration between pharmaceutical companies for drug development that is driving the market growth. Also, they are used in many chronic diseases that restore market growth. However, the high cost is associated with drug development that is restraining the market. Whereas purchasing power has increased among emerging economies that is an opportunity for market growth. Also, research and development activities are performed by pharmaceutical companies that are increasing the market demand in the forecast period.
MARKET SCOPE
The "Oral Proteins and Peptides Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of in oral proteins and peptides market with detailed market segmentation by drug type, application and geography. The oral proteins and peptides market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in oral proteins and peptides market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The oral proteins and peptides market is segmented on the basis of drug type and by application. Based on drug type the market is segmented as octreotide, linaclotide, insulin, plecanatide and calcitonin. On the basis of application the market is categorized as hormonal disorders, gastric & digestive disorders, diabetes and bone diseases.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in oral proteins and peptides market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The oral proteins and peptides market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting oral proteins and peptides market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the oral proteins and peptides market in these regions.
The report covers key developments in the in oral proteins and peptides market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in Oral Proteins and Peptides market are anticipated to have lucrative growth opportunities in the future with the rising demand for in oral proteins and peptides market in the global market. Below mentioned is the list of few companies engaged in the Oral Proteins and Peptides market.
The report also includes the profiles of key in oral proteins and peptides market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Oral protein and Peptides are an important class of medicines that are administered through the oral route to treat the diseases, which include hormonal, gastric, and metabolic disorders. The oral protein and peptides have a significant potential to improve human health and are finding applications in the treatment of several diseases. Oral protein and peptides are used in many chronic disease, diabetes is one of them.
MARKET DYNAMICS
The oral proteins and peptides market is increasing its collaboration between pharmaceutical companies for drug development that is driving the market growth. Also, they are used in many chronic diseases that restore market growth. However, the high cost is associated with drug development that is restraining the market. Whereas purchasing power has increased among emerging economies that is an opportunity for market growth. Also, research and development activities are performed by pharmaceutical companies that are increasing the market demand in the forecast period.
MARKET SCOPE
The "Oral Proteins and Peptides Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of in oral proteins and peptides market with detailed market segmentation by drug type, application and geography. The oral proteins and peptides market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in oral proteins and peptides market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The oral proteins and peptides market is segmented on the basis of drug type and by application. Based on drug type the market is segmented as octreotide, linaclotide, insulin, plecanatide and calcitonin. On the basis of application the market is categorized as hormonal disorders, gastric & digestive disorders, diabetes and bone diseases.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in oral proteins and peptides market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The oral proteins and peptides market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting oral proteins and peptides market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the oral proteins and peptides market in these regions.
The report covers key developments in the in oral proteins and peptides market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in Oral Proteins and Peptides market are anticipated to have lucrative growth opportunities in the future with the rising demand for in oral proteins and peptides market in the global market. Below mentioned is the list of few companies engaged in the Oral Proteins and Peptides market.
The report also includes the profiles of key in oral proteins and peptides market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Allergan Plc.
- AstraZeneca PLC
- Biocon Limited
- Chiasma Inc.
- Generex Biotechnology Corp.
- Novo Nordisk A/S
- Oramed Pharmaceuticals Inc.
- Proxima Concepts Limited (Diabetology Ltd.)
- Synergy Pharmaceuticals Inc.
- Tarsa Therapeutics Inc.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Oral Proteins And Peptides Market - By Drug Type
1.3.2 Oral Proteins And Peptides Market - By Application
1.3.3 Oral Proteins And Peptides Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ORAL PROTEINS AND PEPTIDES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ORAL PROTEINS AND PEPTIDES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. ORAL PROTEINS AND PEPTIDES MARKET - GLOBAL MARKET ANALYSIS
6.1. ORAL PROTEINS AND PEPTIDES - GLOBAL MARKET OVERVIEW
6.2. ORAL PROTEINS AND PEPTIDES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ORAL PROTEINS AND PEPTIDES MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. OCTREOTIDE
7.3.1. Overview
7.3.2. Octreotide Market Forecast and Analysis
7.4. LINACLOTIDE
7.4.1. Overview
7.4.2. Linaclotide Market Forecast and Analysis
7.5. INSULIN
7.5.1. Overview
7.5.2. Insulin Market Forecast and Analysis
7.6. PLECANATIDE
7.6.1. Overview
7.6.2. Plecanatide Market Forecast and Analysis
7.7. CALCITONIN
7.7.1. Overview
7.7.2. Calcitonin Market Forecast and Analysis
8. ORAL PROTEINS AND PEPTIDES MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HORMONAL DISORDERS
8.3.1. Overview
8.3.2. Hormonal Disorders Market Forecast and Analysis
8.4. GASTRIC AND DIGESTIVE DISORDERS
8.4.1. Overview
8.4.2. Gastric and Digestive Disorders Market Forecast and Analysis
8.5. DIABETES
8.5.1. Overview
8.5.2. Diabetes Market Forecast and Analysis
8.6. BONE DISEASES
8.6.1. Overview
8.6.2. Bone Diseases Market Forecast and Analysis
9. ORAL PROTEINS AND PEPTIDES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Oral Proteins And Peptides Market Overview
9.1.2 North America Oral Proteins And Peptides Market Forecasts and Analysis
9.1.3 North America Oral Proteins And Peptides Market Forecasts and Analysis - By Drug Type
9.1.4 North America Oral Proteins And Peptides Market Forecasts and Analysis - By Application
9.1.5 North America Oral Proteins And Peptides Market Forecasts and Analysis - By Countries
9.1.5.1 United States Oral Proteins And Peptides Market
9.1.5.1.1 United States Oral Proteins And Peptides Market by Drug Type
9.1.5.1.2 United States Oral Proteins And Peptides Market by Application
9.1.5.2 Canada Oral Proteins And Peptides Market
9.1.5.2.1 Canada Oral Proteins And Peptides Market by Drug Type
9.1.5.2.2 Canada Oral Proteins And Peptides Market by Application
9.1.5.3 Mexico Oral Proteins And Peptides Market
9.1.5.3.1 Mexico Oral Proteins And Peptides Market by Drug Type
9.1.5.3.2 Mexico Oral Proteins And Peptides Market by Application
9.2. EUROPE
9.2.1 Europe Oral Proteins And Peptides Market Overview
9.2.2 Europe Oral Proteins And Peptides Market Forecasts and Analysis
9.2.3 Europe Oral Proteins And Peptides Market Forecasts and Analysis - By Drug Type
9.2.4 Europe Oral Proteins And Peptides Market Forecasts and Analysis - By Application
9.2.5 Europe Oral Proteins And Peptides Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Oral Proteins And Peptides Market
9.2.5.1.1 Germany Oral Proteins And Peptides Market by Drug Type
9.2.5.1.2 Germany Oral Proteins And Peptides Market by Application
9.2.5.2 France Oral Proteins And Peptides Market
9.2.5.2.1 France Oral Proteins And Peptides Market by Drug Type
9.2.5.2.2 France Oral Proteins And Peptides Market by Application
9.2.5.3 Italy Oral Proteins And Peptides Market
9.2.5.3.1 Italy Oral Proteins And Peptides Market by Drug Type
9.2.5.3.2 Italy Oral Proteins And Peptides Market by Application
9.2.5.4 Spain Oral Proteins And Peptides Market
9.2.5.4.1 Spain Oral Proteins And Peptides Market by Drug Type
9.2.5.4.2 Spain Oral Proteins And Peptides Market by Application
9.2.5.5 United Kingdom Oral Proteins And Peptides Market
9.2.5.5.1 United Kingdom Oral Proteins And Peptides Market by Drug Type
9.2.5.5.2 United Kingdom Oral Proteins And Peptides Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Oral Proteins And Peptides Market Overview
9.3.2 Asia-Pacific Oral Proteins And Peptides Market Forecasts and Analysis
9.3.3 Asia-Pacific Oral Proteins And Peptides Market Forecasts and Analysis - By Drug Type
9.3.4 Asia-Pacific Oral Proteins And Peptides Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Oral Proteins And Peptides Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Oral Proteins And Peptides Market
9.3.5.1.1 Australia Oral Proteins And Peptides Market by Drug Type
9.3.5.1.2 Australia Oral Proteins And Peptides Market by Application
9.3.5.2 China Oral Proteins And Peptides Market
9.3.5.2.1 China Oral Proteins And Peptides Market by Drug Type
9.3.5.2.2 China Oral Proteins And Peptides Market by Application
9.3.5.3 India Oral Proteins And Peptides Market
9.3.5.3.1 India Oral Proteins And Peptides Market by Drug Type
9.3.5.3.2 India Oral Proteins And Peptides Market by Application
9.3.5.4 Japan Oral Proteins And Peptides Market
9.3.5.4.1 Japan Oral Proteins And Peptides Market by Drug Type
9.3.5.4.2 Japan Oral Proteins And Peptides Market by Application
9.3.5.5 South Korea Oral Proteins And Peptides Market
9.3.5.5.1 South Korea Oral Proteins And Peptides Market by Drug Type
9.3.5.5.2 South Korea Oral Proteins And Peptides Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Oral Proteins And Peptides Market Overview
9.4.2 Middle East and Africa Oral Proteins And Peptides Market Forecasts and Analysis
9.4.3 Middle East and Africa Oral Proteins And Peptides Market Forecasts and Analysis - By Drug Type
9.4.4 Middle East and Africa Oral Proteins And Peptides Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Oral Proteins And Peptides Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Oral Proteins And Peptides Market
9.4.5.1.1 South Africa Oral Proteins And Peptides Market by Drug Type
9.4.5.1.2 South Africa Oral Proteins And Peptides Market by Application
9.4.5.2 Saudi Arabia Oral Proteins And Peptides Market
9.4.5.2.1 Saudi Arabia Oral Proteins And Peptides Market by Drug Type
9.4.5.2.2 Saudi Arabia Oral Proteins And Peptides Market by Application
9.4.5.3 U.A.E Oral Proteins And Peptides Market
9.4.5.3.1 U.A.E Oral Proteins And Peptides Market by Drug Type
9.4.5.3.2 U.A.E Oral Proteins And Peptides Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Oral Proteins And Peptides Market Overview
9.5.2 South and Central America Oral Proteins And Peptides Market Forecasts and Analysis
9.5.3 South and Central America Oral Proteins And Peptides Market Forecasts and Analysis - By Drug Type
9.5.4 South and Central America Oral Proteins And Peptides Market Forecasts and Analysis - By Application
9.5.5 South and Central America Oral Proteins And Peptides Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Oral Proteins And Peptides Market
9.5.5.1.1 Brazil Oral Proteins And Peptides Market by Drug Type
9.5.5.1.2 Brazil Oral Proteins And Peptides Market by Application
9.5.5.2 Argentina Oral Proteins And Peptides Market
9.5.5.2.1 Argentina Oral Proteins And Peptides Market by Drug Type
9.5.5.2.2 Argentina Oral Proteins And Peptides Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. ORAL PROTEINS AND PEPTIDES MARKET, KEY COMPANY PROFILES
11.1. ALLERGAN PLC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ASTRAZENECA PLC
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. BIOCON LIMITED
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. CHIASMA INC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. GENEREX BIOTECHNOLOGY CORP.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. NOVO NORDISK A/S
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. ORAMED PHARMACEUTICALS INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. PROXIMA CONCEPTS LIMITED (DIABETOLOGY LTD.)
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SYNERGY PHARMACEUTICALS INC.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. TARSA THERAPEUTICS INC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Oral Proteins And Peptides Market - By Drug Type
1.3.2 Oral Proteins And Peptides Market - By Application
1.3.3 Oral Proteins And Peptides Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ORAL PROTEINS AND PEPTIDES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ORAL PROTEINS AND PEPTIDES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. ORAL PROTEINS AND PEPTIDES MARKET - GLOBAL MARKET ANALYSIS
6.1. ORAL PROTEINS AND PEPTIDES - GLOBAL MARKET OVERVIEW
6.2. ORAL PROTEINS AND PEPTIDES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ORAL PROTEINS AND PEPTIDES MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. OCTREOTIDE
7.3.1. Overview
7.3.2. Octreotide Market Forecast and Analysis
7.4. LINACLOTIDE
7.4.1. Overview
7.4.2. Linaclotide Market Forecast and Analysis
7.5. INSULIN
7.5.1. Overview
7.5.2. Insulin Market Forecast and Analysis
7.6. PLECANATIDE
7.6.1. Overview
7.6.2. Plecanatide Market Forecast and Analysis
7.7. CALCITONIN
7.7.1. Overview
7.7.2. Calcitonin Market Forecast and Analysis
8. ORAL PROTEINS AND PEPTIDES MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HORMONAL DISORDERS
8.3.1. Overview
8.3.2. Hormonal Disorders Market Forecast and Analysis
8.4. GASTRIC AND DIGESTIVE DISORDERS
8.4.1. Overview
8.4.2. Gastric and Digestive Disorders Market Forecast and Analysis
8.5. DIABETES
8.5.1. Overview
8.5.2. Diabetes Market Forecast and Analysis
8.6. BONE DISEASES
8.6.1. Overview
8.6.2. Bone Diseases Market Forecast and Analysis
9. ORAL PROTEINS AND PEPTIDES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Oral Proteins And Peptides Market Overview
9.1.2 North America Oral Proteins And Peptides Market Forecasts and Analysis
9.1.3 North America Oral Proteins And Peptides Market Forecasts and Analysis - By Drug Type
9.1.4 North America Oral Proteins And Peptides Market Forecasts and Analysis - By Application
9.1.5 North America Oral Proteins And Peptides Market Forecasts and Analysis - By Countries
9.1.5.1 United States Oral Proteins And Peptides Market
9.1.5.1.1 United States Oral Proteins And Peptides Market by Drug Type
9.1.5.1.2 United States Oral Proteins And Peptides Market by Application
9.1.5.2 Canada Oral Proteins And Peptides Market
9.1.5.2.1 Canada Oral Proteins And Peptides Market by Drug Type
9.1.5.2.2 Canada Oral Proteins And Peptides Market by Application
9.1.5.3 Mexico Oral Proteins And Peptides Market
9.1.5.3.1 Mexico Oral Proteins And Peptides Market by Drug Type
9.1.5.3.2 Mexico Oral Proteins And Peptides Market by Application
9.2. EUROPE
9.2.1 Europe Oral Proteins And Peptides Market Overview
9.2.2 Europe Oral Proteins And Peptides Market Forecasts and Analysis
9.2.3 Europe Oral Proteins And Peptides Market Forecasts and Analysis - By Drug Type
9.2.4 Europe Oral Proteins And Peptides Market Forecasts and Analysis - By Application
9.2.5 Europe Oral Proteins And Peptides Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Oral Proteins And Peptides Market
9.2.5.1.1 Germany Oral Proteins And Peptides Market by Drug Type
9.2.5.1.2 Germany Oral Proteins And Peptides Market by Application
9.2.5.2 France Oral Proteins And Peptides Market
9.2.5.2.1 France Oral Proteins And Peptides Market by Drug Type
9.2.5.2.2 France Oral Proteins And Peptides Market by Application
9.2.5.3 Italy Oral Proteins And Peptides Market
9.2.5.3.1 Italy Oral Proteins And Peptides Market by Drug Type
9.2.5.3.2 Italy Oral Proteins And Peptides Market by Application
9.2.5.4 Spain Oral Proteins And Peptides Market
9.2.5.4.1 Spain Oral Proteins And Peptides Market by Drug Type
9.2.5.4.2 Spain Oral Proteins And Peptides Market by Application
9.2.5.5 United Kingdom Oral Proteins And Peptides Market
9.2.5.5.1 United Kingdom Oral Proteins And Peptides Market by Drug Type
9.2.5.5.2 United Kingdom Oral Proteins And Peptides Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Oral Proteins And Peptides Market Overview
9.3.2 Asia-Pacific Oral Proteins And Peptides Market Forecasts and Analysis
9.3.3 Asia-Pacific Oral Proteins And Peptides Market Forecasts and Analysis - By Drug Type
9.3.4 Asia-Pacific Oral Proteins And Peptides Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Oral Proteins And Peptides Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Oral Proteins And Peptides Market
9.3.5.1.1 Australia Oral Proteins And Peptides Market by Drug Type
9.3.5.1.2 Australia Oral Proteins And Peptides Market by Application
9.3.5.2 China Oral Proteins And Peptides Market
9.3.5.2.1 China Oral Proteins And Peptides Market by Drug Type
9.3.5.2.2 China Oral Proteins And Peptides Market by Application
9.3.5.3 India Oral Proteins And Peptides Market
9.3.5.3.1 India Oral Proteins And Peptides Market by Drug Type
9.3.5.3.2 India Oral Proteins And Peptides Market by Application
9.3.5.4 Japan Oral Proteins And Peptides Market
9.3.5.4.1 Japan Oral Proteins And Peptides Market by Drug Type
9.3.5.4.2 Japan Oral Proteins And Peptides Market by Application
9.3.5.5 South Korea Oral Proteins And Peptides Market
9.3.5.5.1 South Korea Oral Proteins And Peptides Market by Drug Type
9.3.5.5.2 South Korea Oral Proteins And Peptides Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Oral Proteins And Peptides Market Overview
9.4.2 Middle East and Africa Oral Proteins And Peptides Market Forecasts and Analysis
9.4.3 Middle East and Africa Oral Proteins And Peptides Market Forecasts and Analysis - By Drug Type
9.4.4 Middle East and Africa Oral Proteins And Peptides Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Oral Proteins And Peptides Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Oral Proteins And Peptides Market
9.4.5.1.1 South Africa Oral Proteins And Peptides Market by Drug Type
9.4.5.1.2 South Africa Oral Proteins And Peptides Market by Application
9.4.5.2 Saudi Arabia Oral Proteins And Peptides Market
9.4.5.2.1 Saudi Arabia Oral Proteins And Peptides Market by Drug Type
9.4.5.2.2 Saudi Arabia Oral Proteins And Peptides Market by Application
9.4.5.3 U.A.E Oral Proteins And Peptides Market
9.4.5.3.1 U.A.E Oral Proteins And Peptides Market by Drug Type
9.4.5.3.2 U.A.E Oral Proteins And Peptides Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Oral Proteins And Peptides Market Overview
9.5.2 South and Central America Oral Proteins And Peptides Market Forecasts and Analysis
9.5.3 South and Central America Oral Proteins And Peptides Market Forecasts and Analysis - By Drug Type
9.5.4 South and Central America Oral Proteins And Peptides Market Forecasts and Analysis - By Application
9.5.5 South and Central America Oral Proteins And Peptides Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Oral Proteins And Peptides Market
9.5.5.1.1 Brazil Oral Proteins And Peptides Market by Drug Type
9.5.5.1.2 Brazil Oral Proteins And Peptides Market by Application
9.5.5.2 Argentina Oral Proteins And Peptides Market
9.5.5.2.1 Argentina Oral Proteins And Peptides Market by Drug Type
9.5.5.2.2 Argentina Oral Proteins And Peptides Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. ORAL PROTEINS AND PEPTIDES MARKET, KEY COMPANY PROFILES
11.1. ALLERGAN PLC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ASTRAZENECA PLC
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. BIOCON LIMITED
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. CHIASMA INC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. GENEREX BIOTECHNOLOGY CORP.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. NOVO NORDISK A/S
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. ORAMED PHARMACEUTICALS INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. PROXIMA CONCEPTS LIMITED (DIABETOLOGY LTD.)
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SYNERGY PHARMACEUTICALS INC.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. TARSA THERAPEUTICS INC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies
1. Allergan Plc.
2. AstraZeneca PLC
3. Biocon Limited
4. Chiasma Inc.
5. Generex Biotechnology Corp.
6. Novo Nordisk A/S
7. Oramed Pharmaceuticals Inc.
8. Proxima Concepts Limited (Diabetology Ltd.)
9. Synergy Pharmaceuticals Inc.
10. Tarsa Therapeutics Inc.
1. Allergan Plc.
2. AstraZeneca PLC
3. Biocon Limited
4. Chiasma Inc.
5. Generex Biotechnology Corp.
6. Novo Nordisk A/S
7. Oramed Pharmaceuticals Inc.
8. Proxima Concepts Limited (Diabetology Ltd.)
9. Synergy Pharmaceuticals Inc.
10. Tarsa Therapeutics Inc.